vs
Idexx Laboratories（IDXX）とRUSH ENTERPRISES INC \TX\（RUSHA）の財務データ比較。上の社名をクリックして会社を切り替えられます
RUSH ENTERPRISES INC \TX\の直近四半期売上が大きい（$1.7B vs $1.1B、Idexx Laboratoriesの約1.5倍）。Idexx Laboratoriesの純利益率が高く（22.8% vs 3.7%、差は19.1%）。Idexx Laboratoriesの前年同期比売上増加率が高い（14.3% vs -9.0%）。RUSH ENTERPRISES INC \TX\の直近四半期フリーキャッシュフローが多い（$411.6M vs $326.3M）。過去8四半期でIdexx Laboratoriesの売上複合成長率が高い（6.4% vs -6.8%）
IDEXXラボラトリーズは1983年設立の米国多国籍企業で、伴侶動物獣医療、家畜・家禽、水質検査、乳製品分野向けの製品・サービスの開発・製造・流通を手がけています。本社はメイン州ウェストブルックにあり、EMEA地域の拠点はオランダのホーフドルプに置かれています。
ラッシュ・エンタープライズは米国テキサス州ニューブラウンフェルズに本拠を置く商用車ディーラーで、傘下のRush Truck Centersを通じて新車・中古トラックを主力販売している。2019年時点で米国20州に200店舗以上、カナダに14拠点を展開し、2020年にフォーチュン500入りを果たした。
IDXX vs RUSHA — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.1B | $1.7B |
| 純利益 | $248.2M | $61.7M |
| 粗利率 | 60.3% | 20.4% |
| 営業利益率 | 28.9% | 4.9% |
| 純利益率 | 22.8% | 3.7% |
| 売上前年比 | 14.3% | -9.0% |
| 純利益前年比 | 14.8% | 1.8% |
| EPS（希薄化後） | $3.09 | $0.77 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.1B | $1.7B | ||
| Q3 25 | $1.1B | $1.8B | ||
| Q2 25 | $1.1B | $1.8B | ||
| Q1 25 | $998.4M | $1.8B | ||
| Q4 24 | $954.3M | $1.9B | ||
| Q3 24 | $975.5M | $1.8B | ||
| Q2 24 | $1.0B | $1.9B |
| Q1 26 | — | $61.7M | ||
| Q4 25 | $248.2M | $64.3M | ||
| Q3 25 | $274.6M | $66.7M | ||
| Q2 25 | $294.0M | $72.4M | ||
| Q1 25 | $242.7M | $60.3M | ||
| Q4 24 | $216.1M | $74.8M | ||
| Q3 24 | $232.8M | $79.1M | ||
| Q2 24 | $203.3M | $78.7M |
| Q1 26 | — | 20.4% | ||
| Q4 25 | 60.3% | 20.8% | ||
| Q3 25 | 61.8% | 21.0% | ||
| Q2 25 | 62.6% | 20.7% | ||
| Q1 25 | 62.4% | 20.3% | ||
| Q4 24 | 59.8% | 19.3% | ||
| Q3 24 | 61.1% | 21.0% | ||
| Q2 24 | 61.7% | 20.2% |
| Q1 26 | — | 4.9% | ||
| Q4 25 | 28.9% | 5.5% | ||
| Q3 25 | 32.1% | 5.6% | ||
| Q2 25 | 33.6% | 6.0% | ||
| Q1 25 | 31.7% | 5.2% | ||
| Q4 24 | 27.4% | 5.8% | ||
| Q3 24 | 31.2% | 6.7% | ||
| Q2 24 | 26.3% | 6.4% |
| Q1 26 | — | 3.7% | ||
| Q4 25 | 22.8% | 3.8% | ||
| Q3 25 | 24.8% | 3.7% | ||
| Q2 25 | 26.5% | 3.9% | ||
| Q1 25 | 24.3% | 3.4% | ||
| Q4 24 | 22.7% | 3.9% | ||
| Q3 24 | 23.9% | 4.4% | ||
| Q2 24 | 20.3% | 4.1% |
| Q1 26 | — | $0.77 | ||
| Q4 25 | $3.09 | $0.81 | ||
| Q3 25 | $3.40 | $0.83 | ||
| Q2 25 | $3.63 | $0.90 | ||
| Q1 25 | $2.96 | $0.73 | ||
| Q4 24 | $2.62 | $-95.13 | ||
| Q3 24 | $2.80 | $0.97 | ||
| Q2 24 | $2.44 | $97.00 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $180.1M | — |
| 総負債低いほど良い | $450.0M | $277.8M |
| 株主資本純資産 | $1.6B | $2.3B |
| 総資産 | $3.4B | $4.5B |
| 負債/資本比率低いほどレバレッジが低い | 0.28× | 0.12× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | — | ||
| Q4 25 | $180.1M | $212.6M | ||
| Q3 25 | $208.2M | $242.0M | ||
| Q2 25 | $164.6M | $211.1M | ||
| Q1 25 | $164.0M | $228.7M | ||
| Q4 24 | $288.3M | $228.1M | ||
| Q3 24 | $308.6M | $185.1M | ||
| Q2 24 | $401.6M | $167.3M |
| Q1 26 | — | $277.8M | ||
| Q4 25 | $450.0M | $274.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $617.8M | $408.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.3B | ||
| Q4 25 | $1.6B | $2.2B | ||
| Q3 25 | $1.6B | $2.2B | ||
| Q2 25 | $1.5B | $2.2B | ||
| Q1 25 | $1.4B | $2.2B | ||
| Q4 24 | $1.6B | $2.1B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.6B | $2.0B |
| Q1 26 | — | $4.5B | ||
| Q4 25 | $3.4B | $4.4B | ||
| Q3 25 | $3.4B | $4.6B | ||
| Q2 25 | $3.3B | $4.7B | ||
| Q1 25 | $3.2B | $4.7B | ||
| Q4 24 | $3.3B | $4.6B | ||
| Q3 24 | $3.4B | $4.6B | ||
| Q2 24 | $3.4B | $4.5B |
| Q1 26 | — | 0.12× | ||
| Q4 25 | 0.28× | 0.12× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.39× | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $355.8M | — |
| フリーキャッシュフロー営業CF - 設備投資 | $326.3M | $411.6M |
| FCFマージンFCF / 売上 | 29.9% | 24.4% |
| 設備投資強度設備投資 / 売上 | 2.7% | 2.0% |
| キャッシュ転換率営業CF / 純利益 | 1.43× | — |
| 直近12ヶ月FCF直近4四半期 | $1.1B | $828.4M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | — | ||
| Q4 25 | $355.8M | $112.9M | ||
| Q3 25 | $402.3M | $367.8M | ||
| Q2 25 | $185.7M | $227.6M | ||
| Q1 25 | $238.0M | $153.5M | ||
| Q4 24 | $262.0M | $392.3M | ||
| Q3 24 | $220.1M | $111.7M | ||
| Q2 24 | $248.3M | $270.6M |
| Q1 26 | — | $411.6M | ||
| Q4 25 | $326.3M | $31.9M | ||
| Q3 25 | $371.2M | $271.2M | ||
| Q2 25 | $151.6M | $113.8M | ||
| Q1 25 | $207.9M | $45.1M | ||
| Q4 24 | $232.8M | $263.5M | ||
| Q3 24 | $192.0M | $-20.0M | ||
| Q2 24 | $215.0M | $177.2M |
| Q1 26 | — | 24.4% | ||
| Q4 25 | 29.9% | 1.9% | ||
| Q3 25 | 33.6% | 15.2% | ||
| Q2 25 | 13.7% | 6.2% | ||
| Q1 25 | 20.8% | 2.6% | ||
| Q4 24 | 24.4% | 13.7% | ||
| Q3 24 | 19.7% | -1.1% | ||
| Q2 24 | 21.4% | 9.1% |
| Q1 26 | — | 2.0% | ||
| Q4 25 | 2.7% | 4.8% | ||
| Q3 25 | 2.8% | 5.4% | ||
| Q2 25 | 3.1% | 6.2% | ||
| Q1 25 | 3.0% | 6.2% | ||
| Q4 24 | 3.1% | 6.7% | ||
| Q3 24 | 2.9% | 7.3% | ||
| Q2 24 | 3.3% | 4.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | 1.75× | ||
| Q3 25 | 1.47× | 5.51× | ||
| Q2 25 | 0.63× | 3.14× | ||
| Q1 25 | 0.98× | 2.55× | ||
| Q4 24 | 1.21× | 5.25× | ||
| Q3 24 | 0.95× | 1.41× | ||
| Q2 24 | 1.22× | 3.44× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
RUSHA
| New and used commercial vehicle sales | $955.1M | 57% |
| Aftermarket products and services sales | $627.2M | 37% |
| Lease and rental sales | $92.3M | 5% |
| Finance and insurance | $5.6M | 0% |
